TY  - JOUR 
AU  - García-Cano, Jesús
AU  - Roche, Olga
AU  - Cimas, Francisco J
AU  - Pascual-Serra, Raquel
AU  - Ortega-Muelas, Marta
AU  - Fernández-Aroca, Diego M
AU  - Sánchez-Prieto, Ricardo
PY  - 2016
SN  - 2296-634X
UR  - http://hdl.handle.net/20.500.12020/1148
AB  - The p38MAPK signaling pathway was initially described as a stress response mechanism. In fact, during previous decades, it was considered a pathway with little interest in oncology especially in comparison with other MAPKs such as ERK1/2, known to be...
LA  - en
PB  - Frontiers Media
TI  - p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
DO  - https://doi.org/10.3389/fcell.2016.00069
T2  - Frontiers in Cell and Developmental Biology
M2  - 60
KW  - p38MAPK
KW  - p38MAPK Inhibitors
KW  - Targeted Therapy
KW  - Chemotherapy
KW  - Cancer
KW  - Resistance
KW  - Sensitivity
VL  - 4
ER  -